Girentuximab Recruiting Phase 2 Trials for Cervical Cancer / Hepatocellular Carcinoma / Esophageal Cancer / Gastric Cancer / Pancreatic Ductal Adenocarcinoma (PDAC) / Soft Tissue Sarcoma / Non-Small Cell Lung Cancer (NSCLC) / Small Cell Lung Cancer (SCLC) / Cholangiocarcinoma / Epithelial Ovarian Cancer / Colorectal Cancer / Glioblastoma Multiforme (GBM) / Squamous Cell Carcinoma of the Head and Neck (SCCHN) / Nasopharyngeal Carcinoma (NPC) Diagnostic